Treatment and prevention of Staphylococcus epidermidis experimental biomaterial-associated infection by bactericidal peptide 2

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 12, 2006, Pages 3977-3983

  Kwakman, Paulus H S ^a   Te Velde, Anje A ^a   Vandenbroucke Grauls, Christina M J E ^a,c   Van Deventer, Sander J H ^b   Zaat, Sebastian A J ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERICIDAL PEPTIDE 2; POLYPEPTIDE ANTIBIOTIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BIOMATERIAL ASSOCIATED INFECTION; COLONY FORMING UNIT; CONTROLLED STUDY; DEVICE INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS;

ANIMALS; ANTI-BACTERIAL AGENTS; CATHETERS, INDWELLING; DRUG RESISTANCE, BACTERIAL; HUMANS; INJECTIONS, SUBCUTANEOUS; KINETICS; MICE; MICE, INBRED C57BL; PEPTIDES; SPECIFIC PATHOGEN-FREE ORGANISMS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 33845238238     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00575-06     Document Type: Article

References (53)

1. Aarbiou, J., G. S. Tjabringa, R. M. Verhoosel, D. K. Ninaber, S. R. White, L. T. Peltenburg, K. F. Rabe, and P. S. Hiemstra. 2006. Mechanisms of cell death induced by the neutrophil antimicrobial peptides alpha-defensins and LL-37. Inflamm. Res. 55:119-127.
2. Abraham, P. R., B. J. Appelmelk, and S. J. H. van Deventer. September 2003. Synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome. U.S. patent 6624140.
3. Balaban, N., Y. Gov, A. Giacometti, O. Cirioni, R. Ghiselli, F. Mocchegiani, F. Orlando, G. D'Amato, V. Saba, G. Scalise, S. Bernes, and A. Mor. 2004. A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci. Antimicrob. Agents Chemother. 48:2544-2550.
4. Bals, R., X. Wang, M. Zasloff, and J. M. Wilson. 1998. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc. Natl. Acad. Sci. USA 95:9541-9546.
5. Barie, P. S. 1998. Antibiotic-resistant gram-positive cocci: implications for surgical practice. World J. Surg. 22:118-126.
6. Belas, R., J. Manos, and R. Suvanasuthi. 2004. Proteus mirabilis ZapA metalloprotease degrades a broad spectrum of substrates, including antimicrobial peptides. Infect. Immun. 72:5159-5167.
7. Boelens, J. J., J. Dankert, J. L. Murk, J. J. Weening, T. van der Poll, K. P. Dingemans, L. Koole, J. D. Laman, and S. A. J. Zaat. 2000. Biomaterial-associated persistence of Staphylococcus epidermidis in pericatheter macrophages. J. Infect. Dis. 181:1337-1349.
8. Boelens, J. J., S. A. J. Zaat, J. Meeldijk, and J. Dankert. 2000. Subcutaneous abscess formation around catheters induced by viable and nonviable Staphylococcus epidermidis as well as by small amounts of bacterial cell wall components. J. Biomed. Mater. Res. 50:546-556.
9. Boelens, J. J., S. A. J. Zaat, J. L. Murk, J. J. Weening, T. van der Poll, and J. Dankert. 2000. Enhanced susceptibility to subcutaneous abscess formation and persistent infection around catheters is associated with sustained interleukin-1beta levels. Infect. Immun. 68:1692-1695.
10. Boman, H. G., B. Agerberth, and A. Boman. 1993. Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine. Infect. Immun. 61:2978-2984.
11. Christensen, G. D., W. A. Simpson, A. L. Bisno, and E. H. Beachey. 1982. Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect. Immun. 37:318-326.
12. Cirioni, O., A. Giacometti, R. Ghiselli, G. Dell'Acqua, Y. Gov, W. Kamysz, J. Lukasiak, F. Mocchegiani, F. Orlando, G. D'Amato, N. Balaban, V. Saba, and G. Scalise. 2003. Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides. Circulation 108:767-771.
13. Costerton, J. W., K. J. Cheng, G. G. Geesey, T. I. Ladd, J. C. Nickel, M. Dasgupta, and T. J. Marrie. 1987. Bacterial biofilms in nature and disease. Annu. Rev. Microbiol. 41:435-464.
14. Cox, A. D., and S. G. Wilkinson. 1991. Ionizing groups in lipopolysaccharides of Pseudomonas cepacia in relation to antibiotic resistance. Mol. Microbiol. 5:641-646.
15. Da Costa, A., G. Kirkorian, M. Cucherat, F. Delahaye, P. Chevalier, A. Cerisier, K. Isaaz, and P. Touboul. 1998. Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis. Circulation 97:1796-1801.
16. Dankert, J., A. Hogt, and J. Feijen. 1986. Biomedical polymers: bacterial adhesion, colonization, and infection. CRC Crit. Rev. Biocompat. 2:219-301.
17. Dankert, J., J. Van der Werff, S. A. J. Zaat, W. Joldersma, D. Klein, and J. Hess. 1995. Involvement of bactericidal factors from thrombin-stimulated platelets in clearance of adherent viridans streptococci in experimental infective endocarditis. Infect. Immun. 63:663-671.
18. Gotz, F., C. Heilmann, and S. E. Cramton. 2000. Molecular basis of catheter associated infections by staphylococci. Adv. Exp. Med. Biol. 485:103-111.
19. Gristina, A. G., C. D. Hobgood, L. X. Webb, and Q. N. Myrvik. 1987. Adhesive colonization of biomaterials and antibiotic resistance. Biomaterials 8:423-426.
20. Hancock, R. E. 2000. Cationic antimicrobial peptides: towards clinical applications. Expert Opin. Investig. Drugs 9:1723-1729.
21. Hancock, R. E., and A. Patrzykat. 2002. Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics. Curr. Drug Targets Infect. Disord. 2:79-83.
22. Hancock, R. E., and M. G. Scott. 2000. The role of antimicrobial peptides in animal defenses. Proc. Natl. Acad. Sci. USA 97:8856-8861.
23. Hanssen, A. D., and D. R. Osmon. 1999. The use of prophylactic antimicrobial agents during and after hip arthroplasty. Clin. Orthop. Relat. Res. 1999:124-138.
24. Harwig, S. S., T. Ganz, and R. I. Lehrer. 1994. Neutrophil defensins: purification, characterization, and antimicrobial testing. Methods Enzymol. 236:160-172.
25. Henke, P. K., T. M. Bergamini, S. M. Rose, and J. D. Richardson. 1998. Current options in prosthetic vascular graft infection. Am. Surg. 64:39-45.
26. Hoffmann, J. A., F. C. Kafatos, C. A. Janeway, and R. A. Ezekowitz. 1999. Phylogenetic perspectives in innate immunity. Science 284:1313-1318.
27. Isaacson, R. E. 2003. MBI-226. Micrologix/Fujisawa. Curr. Opin. Investig. Drugs 4:999-1003.
28. Jenssen, H., P. Hamill, and R. E. Hancock. 2006. Peptide antimicrobial agents. Clin. Microbiol. Rev. 19:491-511.
29. Kobayashi, S., K. Takeshima, C. B. Park, S. C. Kim, and K. Matsuzaki. 2000. Interactions of the novel antimicrobial peptide buforin 2 with lipid bilayers: proline as a translocation promoting factor. Biochemistry 39:8648-8654.
30. Lehrer, R. I., A. Barton, K. A. Daher, S. S. Harwig, T. Ganz, and M. E. Selsted. 1989. Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J. Clin. Investig. 84:553-561.
31. Levy, O. 2000. Antimicrobial proteins and peptides of blood: templates for novel antimicrobial agents. Blood 96:2664-2672.
32. Levy, S. B. 2002. Active efflux, a common mechanism for biocide and antibiotic resistance. J. Appl. Microbiol. 92(Suppl.):65S-71S.
33. Mack, D., N. Siemssen, and R. Laufs. 1992. Parallel induction by glucose of adherence and a polysaccharide antigen specific for plastic-adherent Staphylococcus epidermidis: evidence for functional relation to intercellular adhesion. Infect. Immun. 60:2048-2057.
34. Maisetta, G., G. Batoni, S. Esin, W. Florio, D. Bottai, F. Favilli, and M. Campa. 2006. In vitro bactericidal activity of human beta-defensin 3 against multidrug-resistant nosocomial strains. Antimicrob. Agents Chemother. 50:806-809.
35. Movahed, M. R., B. Kasravi, and C. S. Bryan. 2004. Prophylactic use of vancomycin in adult cardiology and cardiac surgery. J. Cardiovasc. Pharmacol. Ther. 9:13-20.
36. Nagaoka, I., S. Hirota, S. Yomogida, A. Ohwada, and M. Hirata. 2000. Synergistic actions of antibacterial neutrophil defensins and cathelicidins. Inflamm. Res. 49:73-79.
37. Sampath, L. A., S. M. Tambe, and S. M. Modak. 2001. In vitro and in vivo efficacy of catheters impregnated with antiseptics or antibiotics: evaluation of the risk of bacterial resistance to the antimicrobials in the catheters. Infect. Control Hosp. Epidemiol. 22:640-646.
38. Schierholz, J. M., and J. Beuth. 2001. Implant infections: a haven for opportunistic bacteria. J. Hosp. Infect. 49:87-93.
39. Seifert, H., B. Jansen, and B. Farr. 1997. Catheter-related infections. Marcel Dekker Press, New York, N.Y.
40. Shai, Y. 1999. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta 1462:55-70.
41. Sidorczyk, Z., U. Zahringer, and E. T. Rietschel. 1983. Chemical structure of the lipid A component of the lipopolysaccharide from a Proteus mirabilis Re-mutant. Eur. J. Biochem. 137:15-22.
42. Subbalakshmi, C., and N. Sitaram. 1998. Mechanism of antimicrobial action of indolicidin. FEMS Microbiol. Lett. 160:91-96.
43. Tojo, M., N. Yamashita, D. A. Goldmann, and G. B. Pier. 1988. Isolation and characterization of a capsular polysaccharide adhesin from Staphylococcus epidermidis. J. Infect. Dis. 157:713-722.
44. Tossi, A., L. Sandri, and A. Giangaspero. 2000. Amphipathic, alpha-helical antimicrobial peptides. Biopolymers 55:4-30.
45. Turner, J., Y. Cho, N. N. Dinh, A. J. Waring, and R. I. Lehrer. 1998. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob. Agents Chemother. 42:2206-2214.
46. van Wetering, S., S. P. Mannesse-Lazeroms, M. A. van Sterkenburg, M. R. Daha, J. H. Dijkman, and P. S. Hiemstra. 1997. Effect of defensins on interleukin-8 synthesis in airway epithelial cells. Am. J. Physiol. 272:L888-L896.
47. Vuong, C., S. Kocianova, Y. Yao, A. B. Carmody, and M. Otto. 2004. Increased colonization of indwelling medical devices by quorum-sensing mutants of Staphylococcus epidermidis in vivo. J. Infect. Dis. 190:1498-1505.
48. Waldvogel, F. A., and A. L. Bisno. 2000. Infections associated with indwelling medical devices. ASM Press, Washington, D.C.
49. Yang, L., T. M. Weiss, R. I. Lehrer, and H. W. Huang. 2000. Crystallization of antimicrobial pores in membranes: magainin and protegrin. Biophys. J. 79:2002-2009.
50. Yu, Q., R. I. Lehrer, and J. P. Tam. 2000. Engineered salt-insensitive alpha-defensins with end-to-end circularized structures. J. Biol. Chem. 275:3943-3949.
51. Zaat, S. A. J., P. S. Hiemstra, and J. Dankert. 1994. Pathogenic streptococci, present and future, p. 473-475. Lancer Publication, St. Petersburg, Russia.
52. Zasloff, M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415:389-395.
53. Zhang, L., and T. J. Falla. 2004. Cationic antimicrobial peptides - an update. Expert Opin. Investig. Drugs 13:97-106.